Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
 |
Männedorf, Switzerland, August 9, 2012 – Researchers in the Institute of Applied Microbiology at Giessen University, Germany, have developed a microplate-based assay for online testing of the effects of metal nanoparticles using an Infinite® M200 microplate reader from Tecan. This technique is being used to look at the potential of engineered metal nanoparticles for treating water, inhibiting the growth of bacteria in drinking water at the point of use, and eradicating pharmaceuticals and other micropollutants from waste water. Michael Bunge, senior scientist in the Nanobioengineering group, explained: “It is clear that some metal nanoparticles are toxic to a variety of microorganisms, but we don’t know how and to what extent they affect microbial growth and survival. We have developed a straightforward technique that simultaneously cultivates microbes and uses the Infinite M200 microplate reader to monitor the effects of different sizes and compositions of nanoparticles on bacteria.”
“We chose an Infinite M200 for this application because it is a monochromator-based reader, making it easy to adjust the wavelength down to a resolution of 1 nm, which is particularly important for nanoparticle suspensions with a high background signal. I also knew from previous experience that Tecan systems were reliable. The system itself is very easy to use, and it is saving us so much time on repetitive, laborious tasks.”
To find out more on Tecan’s monochromator-based Infinite M200 microplate reader, visit www.tecan.com/infinite200
For more information please contact
Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).